CAS: | 117048-59-6 | |
分子式: | C18H20O5 | |
分子量: | 316.35 | |
沸点: | 490.3°C | |
熔点: | 84.5-85.5°C | |
英文名称: |
|
货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 | ||||||||||||||||||||||||||||||||||||||||||||||||||
C793015 | MACKLIN | 康普瑞汀 | 10mM in DMSO | 116元/1ml; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||
储存:-20°C, 避光 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
C849460 | MACKLIN | 康普瑞汀 | 98%,LC | 63元/5mg; 110元/25mg; 352元/100mg; 1180元/500mg; 2208元/1g; 7844元/5g; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||
储存:-20°C 状态:结晶粉末 折射率:1.607 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
C2520 | TCI | Combretastatin A4 | >98.0%(HPLC) | 930元/25MG; 5240元/250MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
技术规格
物性(参考值)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
266725 | J&K | Combretastatin A-4 | 98%, 一种 microtubule 抑制剂,能够与 β-tubulin 结合,Kd 值为 0.4 μM | 413元/5MG; 858元/25MG; 2825元/100MG; 20465元/1G; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
产品描述 Combretastatin A4 是一种以 microtubule 为靶点的试剂,其与β-微管蛋白结合,Kd 为 0.4 μM。Phase 3。 靶点(IC50 & Targe) Tubulin β,0.4μM(Kd) 体外研究 Combretastatin A4抑制MDA-MB-231,A549,Hela,HL-60,SF295,HCT-8,MDA-MB435,PC3M,OVCAR-8,NCI-H358M,和淋巴细胞的生长,IC50分别为2.8,3.8,0.9,2.1,6.2,5.3,7.9,4.7,0.37,8,和3.2 nM。[1] [2]1 μM Combretastatin A4抑制35%微管蛋白聚合,10 μM几乎完全阻断微管蛋白聚合。Combretastatin A4表现出高的相对结合能力,达到秋水仙碱结合力的78%。[1] 体内研究 在NT2和MDA-MB-231乳腺肿瘤模型中,Combretastatin A4 (100 mg/kg, i.p.)诱导脂质R1显著减少,并通过电子顺磁共振(EPR)血氧定量法测得pO2下降。[2] Combretastatin A4 (100 mg/kg, i.p.)显著减少雄性NMRI小鼠的Ktrans。[3] 激酶实验 使用 LC-MS/MS 的竞争性结合试验: Colchicine (1.2 μ M)与微管蛋白(1.3 mg/mL)在培养缓冲液(80 mM PIPES,2.0 mM MgCl2,0.5 mM EGTA,pH 6.9)中于37℃下培养1小时。使用不同浓度(0.1− 125 μ M)的Combretastatin A4与原本结合微管蛋白的colchicine竞争。培育后,得到滤液。类似物抑制秋水仙碱结合的能力表示为不存在任何竞争物的对照组的百分比。 细胞实验 Cell lines: MDA-MB-231,A549,和 Hela 细胞 Concentrations: ~3.8 nM Incubation Time: 72 h Method: MDA-MB-231,A549,和HeLa细胞在DMEM培养基(115 units/mL 青霉素G,115 μg/mL 链霉素,和10%胎牛血清)中生长。细胞(5000 细胞/孔)接种于包含50 μL生长培养基的96孔板,培养24小时。移除培养基后,将100 μL包含不同浓度单个类似化合物的新鲜培养基加入到每个孔中,在37 ℃下培养72小时。培养24小时后,细胞中增补50 μL溶于DMSO(每个制剂中少于0.25%)的类似化合物。培养72小时后,加入20 μL刃天青培养2小时,然后在560 nm (激发波长)和590 nm (发射波长)下使用Victor微量滴定板荧光剂记录荧光。对照组为用最大量DMSO (0.25%)处理的细胞,活性为100%,IC50定义为与对照组相比,抑制50%细胞增殖的化合物浓度。 (Only for Reference) 动物实验 Animal Models: 负荷 NT2 和 MDA-MB-231肿瘤的 FVB/N或裸的NMRI雄性小鼠 Formulation: DMSO Dosages: 100 mg/kg Administration: i.p. (Only for Reference) 参考文献 [1] Zheng S, et al. J Med Chem. 2014, 57(8), 3369-3381. [2] Colliez F, et al. Magn Reson Med. 2015, doi: 10.1002/mrm.25642. [3] Fruytier AC, et al. NMR Biomed. 2014, 27(11), 1403-1412. 安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
C7744 | Sigma-Aldrich | Combretastatin A4 | ≥98% (HPLC), powder | 1149.61元/5 MG; 4371.76元/25 MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 考布他汀A4属于秋水仙碱类。 应用 考布他汀A4已被用于:
包装 5, 25 mg in glass bottle 生化/生理作用 考布他汀A4是一种强效的微管靶向剂。 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
234200 | Sigma-Aldrich | Combretastatin A-4-CAS 117048-59-6-Calbiochem | A synthetic Combretum caffrum-derived cell-permeable stilbenoid phenol that competes with colchicine tubulin binding and interferes with tubulin polymerization as well as cellular microtubule assembly | 2846.26元/10 MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 A synthetic Combretum caffrum-derived cell-permeable stilbenoid phenol that competes with colchicine (Cat No. 234115) tubulin binding (by 96.4% at equal molar concentration; Ki = 1.1 µM) and interferes with tubulin polymerization (IC50 = 2-3 µM) as well as cellular microtubule assembly. In addition to its antimitotic and in vitro cancer growth inhibition activity (IC50 = 7 nM in L1210 cultures), CA4 also acts as an antivascular agent and effectively induces tumor cell necrosis in vivo by targeting endothelial cytoskeleton. 包装 Packaged under inert gas 警告 Toxicity: Standard Handling (A) 重悬 Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C. 其他说明 Tron, G.C., et al. 2006. J. Med. Chem.49, 3033. 法律信息 CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
387723 | Fluorochem | Combretastatin A4 | 98% | 2860元/250mg; 7106元/1g; 21318元/5g; 34100元/10g; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
安全信息
|